Thousands of cancer patients in England to benefit from new immunotherapy jab

Injectable pembrolizumab can treat several types of cancer and can be administered in under two minutes Thousands of patients across England each year will benefit from a new immunotherapy treatment that can be used for several types of cancer, the NHS has announced. The injectable form of pembrolizumab, which can be administered in under two minutes, kills cancer cells by blocking a protein called PD-1, which acts as a brake on immune responses, allowing the immune system to recognise and attac

More from World news | The Guardian

Could Iran’s escalating economic crisis weaken negotiating position with US?

World news | The Guardian·4

Security or justice? Syria faces post-Assad reckoning after string of arrests

World news | The Guardian·7

Jim Chalmers rules out fuel excise extension and downplays hopes for tax relief in ‘most responsible’ budget yet

World news | The Guardian·6

‘It’s a world heritage site, but it’s my home’: the last resident of Casa Milà on life in Gaudí’s masterwork

World news | The Guardian·7

Labour MPs say ‘endless drama’ of leadership speculation must stop

World news | The Guardian·8

Bondi beach was where her parents met – and where her father died defending his people

World news | The Guardian·6